Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
10/2010
10/06/2010CN101850116A Method for constructing virus live vector recombinant vaccine by utilizing transposon
10/06/2010CN101850115A Method for producing swine fever live vaccine by using porcine kidney cell line (IBRS-2) and product thereof
10/06/2010CN101402945B Process for producing small RNA recombinant birds adeno-associated virus for expression of infectivity resistant bursa of fabricius disease virus
10/06/2010CN101121938B Method for preparing foot-and-mouth disease antigen
10/05/2010US7807457 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars
10/05/2010US7807455 Generating viral replicon having an increased replication activity in a Huh7 cells using variant viral coding sequences; prevention and treatment of liver inflammation, infection and failure
10/05/2010US7807438 Vessicular composition comprising hepatitis C virus RNA sequences for use in designing drugs for treatment and prevention of viral infection
10/05/2010US7807437 Variants of hepatitis B virus resistant against some nucleoside analogues, but sensitive to others, and uses thereof
10/05/2010US7807179 Reoviridae virus is conjugated to a hydroxylated hydrocarbon or a polycationic polymer to reduce the clearance and immunogenicity; antiproliferative disorders
10/05/2010CA2428662C Small acid-soluble spore protein and uses thereof
09/2010
09/30/2010US20100249181 HIV Protease Inhibiting Compounds
09/30/2010US20100248355 Methods for generating high titer helper-free preparations of released recombinant aav vectors
09/30/2010US20100248215 Sample preparation container and method
09/30/2010US20100248205 Reovirus Clearance of Ras-Mediated Neoplastic Cells from Mixed Cellular Compositions
09/30/2010US20100247572 Viruses encoding mutant membrane protein
09/30/2010US20100247569 Influenza A Virus Vaccines and Inhibitors
09/30/2010US20100247565 Chimeric sindbis-eastern equine encephalitis virus and uses thereof
09/30/2010US20100247559 West nile virus vaccine, and method for production thereof
09/30/2010US20100247520 Mutated netrin 4, fragments thereof and uses thereof as drugs
09/30/2010US20100247490 SIMIAN E ADENOVIRUSES SAdV-39, -25.2, -26, -30, -37, AND -38
09/29/2010EP2233568A1 Novel method for generation of RNA virus
09/29/2010EP2233152A1 High growth reassortant influenza A virus
09/29/2010CN101848995A Recombinant north american type 1 porcine reproductive and respiratory syndrome virus and methods of use
09/29/2010CN101846679A Method for screening recombinant vaccinia virus containing exogenous fusion gene HIV/env/IFN alpha-2b
09/29/2010CN101845444A Capsid protein gene and virus-like particles of shrimp infectious hypodermal and hematopoietic tissue necrosis
09/29/2010CN101845439A Method for using silkworm cultured cell to express antibacterial peptide Cecropin B
09/29/2010CN101845419A Recombinant adenovirus and application thereof
09/29/2010CN101843641A Novel adenoviruses, nucleic acids coding therefor, and use thereof
09/29/2010CN101508977B Separation identification and purification process for chicken source H9N2 avian influenza virus strain and uses thereof
09/28/2010US7803926 Immunology; immunogens; cloning; host cell biosynthesis
09/28/2010US7803918 gene delivery vehicle comprising the isolated and/or recombinant nucleic acid sequence; methods for typing the virus in various samples and diagnosing of disease
09/28/2010US7803621 Plasmid comprised of viral envelope protein for use as nucleic acid transfer tool in gene therapeutic; safe and high-efficiency vector for in-vitro and in-vivo gene transfer; drug delivery systems; for gene therapy and high throughput screening
09/28/2010US7803613 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
09/28/2010US7803385 An isolated reovirus comprising a lambda-3 polypeptide, wherein the lambda-3 polypeptide comprises SEQ ID NO:19; muagenesis- directed; antiproliferative agents; anticarcinogenic agents;antitumor agents; kits
09/28/2010CA2544185C Method of detecting hepatitis c virus
09/23/2010WO2010107847A1 Replication-defective flavivirus vaccine vectors against respiratory syncytial virus
09/23/2010WO2010107405A1 Method for producing peptides which specifically recognize cells of particular types and can be used for therapeutic purposes
09/23/2010WO2010086189A3 Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
09/23/2010WO2010062837A3 Multivalent, drying resistant, evolution-based vaccines
09/23/2010US20100240025 Bacteriophage with Enhanced Lytic Activity
09/23/2010US20100239617 Modified rsv f proteins and methods of their use
09/23/2010US20100239610 Influenza virus-like particles (vlps) comprising hemagglutinin produced within a plant
09/23/2010US20100239609 Formulation of Sugar Solutions for Continuous Ultracentrifugation for Virus Purification
09/23/2010US20100239606 Two-Step Temperature Profile for the Propagation of Viruses
09/23/2010US20100239605 Recombinant Rhinovirus Vectors
09/23/2010US20100239536 Modified Bacteriophage Including an Alpha/Beta Small Acid-Soluble Spore Protein (SASP) Gene
09/23/2010CA2755257A1 Replication-defective flavivirus vaccine vectors against respiratory syncytial virus
09/22/2010EP1554301B1 Dengue vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1 and 2.
09/22/2010CN101842383A Novel plant virus designated tomato marchitez virus
09/21/2010US7799899 Compositions and methods relating to STOP-1
09/21/2010US7799329 Viruses for the treatment of cellular proliferative disorders
09/21/2010CA2404235C Cell-specific adenovirus vectors comprising an internal ribosome entry site
09/21/2010CA2343074C Akt nucleic acids, polypeptides, and uses thereof
09/21/2010CA2330241C Attenuated pestiviruses
09/21/2010CA2327835C Methods and modified cells for the treatment of cancer
09/18/2010CA2697169A1 Compositions and methods for augmenting activity of oncolytic viruses
09/16/2010WO2010105020A2 Baculoviruses with enhanced virion production and a method for the production of baculoviruses
09/16/2010WO2010103488A1 Dengue virus-like particle and uses thereof
09/16/2010US20100235936 Zinc-finger nuclease and rna interference mediated inactivation of viral genomes
09/16/2010US20100234434 Flavivirus inhibition by sultams and related compounds
09/16/2010US20100233785 Novel methods and interferon deficient substrates for the propagation of viruses
09/16/2010US20100233758 Protein increasing cell infectivity of herpes simplex virus and use thereof
09/16/2010US20100233720 Biological reagents and methods to verify the efficiency of sample preparation and nucleic acid amplification and/or detection
09/16/2010US20100233678 Tunable affinity ligands for the separation and detection of target substances
09/16/2010US20100233674 Cells for detection and production of influenza and parainfluenza viruses
09/16/2010US20100233215 IMMUNOTHERAPY BY USING CELL CAPABLE OF CO-EXPRESSING TARGET ANTIGEN AND CD1d AND PULSED WITH CD1d LIGAND
09/16/2010US20100233210 Subgenomic replicons of the flavivirus dengue
09/16/2010US20100233208 Methods of Treating and Preventing Neurological Symptoms Caused by Avian Reovirus and Novel Associated Characteristics
09/16/2010US20100233206 Marek's Disease Virus Vaccine Compositions and Methods of Using Thereof
09/16/2010US20100233202 Novel viral vector
09/16/2010US20100233157 Human antibodies against human fas and their use
09/16/2010US20100233125 Chimeric adenovirus, method for producing the same and pharmaceutical using the same
09/16/2010US20100233078 Microorganisms for imaging and/or treatment of tumors
09/16/2010CA2754603A1 Non-integrating retroviral vector vaccines
09/15/2010EP2227547A1 Chimeric construct of mungbean yellow mosaic india virus (mymiv) and its uses thereof
09/15/2010EP1533381B1 Adenovirus vector
09/15/2010EP1309617B1 Process for the selection of hiv-1 subtype c isolates, selected hiv-1 subtype isolates, their genes and modifications and derivatives thereof
09/15/2010CN1616654B Inactivating and purifying method for SARS virus and method for preparing said inactivated virus vaccine and said vaccine
09/15/2010CN101835896A Production and use of epitope-tagged hepatitis c virus particle
09/15/2010CN101833002A Antibody indirect immunofluorescence test method for distinguishing immune animal infected with influenza A virus
09/15/2010CN101831412A Method for producing porcine reproductive and respiratory syndrome viruses (PRRSV) in large scale
09/15/2010CN101831411A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
09/15/2010CN101831410A Preparation method of recombinant enterovirus 71 type virus-like particles
09/15/2010CN101831409A Method for separating marine algae viruses by high-flux tangential flow with virus activity maintaining
09/15/2010CN101831408A Hemangioma pathotype J subgroup avian leucosis mutant virus strain and construction method thereof
09/14/2010US7794998 vectors and vaccines for use in humans against infection and disease; human T-lymphotropic virus
09/14/2010US7794928 Norovirus detection, methods and compositions therefor
09/14/2010US7794507 Textile treatment
09/14/2010CA2166406C Recombinant swinepox virus
09/12/2010CA2658259A1 Dengue virus-like particle and uses thereof
09/10/2010WO2010099960A2 Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essential consisting of vp3
09/10/2010CA2754335A1 Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essentially consisting of vp3
09/09/2010US20100227407 Aav4 vector and uses thereof
09/09/2010US20100227376 Method of obtaining bacteriophage preparation
09/09/2010US20100227311 Tissue culture system for production of hepatitis c virus
09/09/2010US20100226940 Herpes simplex virus mutant icp0
09/09/2010US20100226939 Formulations for preservation of rotavirus
09/09/2010US20100226938 Cellular and viral inactivation
09/09/2010US20100226890 Bacteriophage and their uses
09/09/2010US20100226882 Linked diimidazole antivirals
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 267